Mechanistically, CuB’s antitumor activity involves inhibition of STAT3 phosphorylation, which elevates ROS levels and activates the ER stress pathway (eIF2α/CHOP), ultimately inducing GBM cell apoptosis (Fig. 6). The gene discussed is EIF2A; the disease is glioblastoma.